Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity

BACKGROUND: Breast cancer is the most common female cancer worldwide. Effective therapies including doxorubicin and trastuzumab have improved survival, but are associated with a substantial risk of cardiovascular disease. Mechanisms underlying cancer treatment-induced cardiotoxicity (CTC) are poorly...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Rebecca K., Kim, Bang-Jin, Shah, Payal D., Carver, Joseph, Ky, Bonnie, Ryeom, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054404/
https://www.ncbi.nlm.nih.gov/pubmed/33875012
http://dx.doi.org/10.1186/s40959-021-00100-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054404/
https://www.ncbi.nlm.nih.gov/pubmed/33875012
http://dx.doi.org/10.1186/s40959-021-00100-3

Ejemplares similares